financetom
Business
financetom
/
Business
/
Braze Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Fiscal 2026 Outlook Raised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Braze Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Fiscal 2026 Outlook Raised
Mar 10, 2026 9:59 PM

04:19 PM EST, 12/09/2025 (MT Newswires) -- Braze (BRZE) reported late Tuesday its fiscal Q3 non-GAAP earnings of $0.06 per diluted share, up from $0.02 per share a year earlier.

Analysts polled by FactSet expected $0.06.

Revenue for the quarter ended Oct. 31 was $190.8 million, up from $152.1 million a year earlier.

Analysts surveyed by FactSet expected $184.2 million.

The company said it expects fiscal Q4 non-GAAP EPS of $0.13 to $0.14 on revenue of $197.5 million to $198.5 million. Analysts surveyed by FactSet expect non-GAAP EPS of $0.13 on revenue of $192.8 million.

For fiscal 2026, Braze now expects non-GAAP EPS of $0.42 to $0.43 on revenue of $730.5 million to $731.5 million. It previously expected non-GAAP EPS of $0.41 to $0.42 on revenue of $717 million to $720 million.

Analysts surveyed by FactSet are looking for non-GAAP EPS of $0.41 on revenue of $719.2 million.

Shares of Braze were up 8% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chevron misses earnings estimate as refining posts first loss in four years
Chevron misses earnings estimate as refining posts first loss in four years
Jan 31, 2025
(Reuters) - Chevron Corp ( CVX ) reported fourth-quarter earnings below Wall Street estimates on Friday as weak margins pushed its refining business into a loss for the first time since 2020. The second-largest U.S. oil producer posted total earnings of $3.24 billion for the three months ended Dec. 31, up from $2.26 billion in the same period last year....
Top Indian drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales
Top Indian drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales
Jan 31, 2025
By Kashish Tandon and Rishika Sadam HYDERABAD/BENGALURU Jan 31 (Reuters) - Sun Pharmaceutical, India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong sales in the domestic market. The Mumbai-based firm's consolidated net profit rose 15% to 29.03 billion rupees ($335.3 million) in the third quarter, beating analysts' average estimate of 28.81 billion rupees, according...
Analysis-OpenAI cites US roots to dodge India courts, but lawyers say case can be heard
Analysis-OpenAI cites US roots to dodge India courts, but lawyers say case can be heard
Jan 31, 2025
NEW DELHI (Reuters) - OpenAI faces an uphill climb as it argues that Indian courts cannot hear lawsuits about its U.S.-based business in the country, where Telegram has failed with similar defences and U.S. technology firms have faced government heat on compliance. OpenAI, which counts India as its second biggest market with millions of users, is locked in an intense...
Chevron misses earnings estimate as refining posts first loss in four years
Chevron misses earnings estimate as refining posts first loss in four years
Jan 31, 2025
Jan 31 (Reuters) - Chevron Corp ( CVX ) reported fourth-quarter earnings below Wall Street estimates on Friday as weak margins pushed its refining business into a loss for the first time since 2020. The second-largest U.S. oil producer posted total earnings of $3.24 billion for the three months ended Dec. 31, up from $2.26 billion in the same period...
Copyright 2023-2026 - www.financetom.com All Rights Reserved